“…Nevertheless, the majority of studies using 1 H NMR spectroscopy still predominantly rely on exclusive 1 H NMR usage. Only a limited few have established connections between toxicity bioassays and compound abundance, , compared the presence of diseases and physiological parameters, ,,,, or have used additional complementary analytical techniques to quantify and confirm metabolites of interest. ,,,, Multiomics combinations with transcriptomics (quantitative real-time PCR and RNA sequencing), proteomics (LC-MS proteomics with gene ontology enrichment analysis), and metabolomics with the use of other analytical techniques (Fourier-transform infrared spectroscopy (FT-IR), GC-MS, and LC-MS) were limited to five studies. ,,,, …”